Skip to content

Safety and Efficacy of ESWL for Geriatric Patients With Chronic Pancreatitis

Safety and Efficacy of Extracorporeal Shock Wave Lithotripsy for Geriatric Patients With Chronic Pancreatitis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03373682
Acronym
ESWL
Enrollment
1404
Registered
2017-12-14
Start date
2011-01-01
Completion date
2018-04-30
Last updated
2017-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pancreatitis, Extracorporeal Shock Wave Lithotripsy, Geriatric

Brief summary

Pancreatic extracorporeal shock wave lithotripsy (P-ESWL) is recommended as the first-line treatment for pancreatic stones. However, how well P-ESWL performs in geriatric patients remains unclear. The investigators aimed to evaluate the safety and efficacy of P-ESWL for geriatric patients with chronic pancreatitis.

Detailed description

This prospective observational study was conducted in patients with painful chronic pancreatitis who underwent P-ESWL. Patients aged over 65 years were included in the geriatric group; patients aged under 65 years who underwent P-ESWL in the same period were assigned to the control group. For investigation of long-term follow-up, the geriatric group were matched with patients from the control group in a 1:1 ratio. The primary outcomes were P-ESWL complications and pain relief. The secondary outcomes included: stone clearance, physical and mental health, quality of life score, and body weight.

Interventions

None listed

Sponsors

Changhai Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients with painful chronic pancreatitis and radiopaque stones of ≥5mm.

Exclusion criteria

* Patients with a suspected or established malignant mass or pancreatic ascites, and pregnant patients.

Design outcomes

Primary

MeasureTime frameDescription
P-ESWL complicationsApril 30, 2016The complications after P-ESWL. Including post-ESWL pancreatitis, bleeding, infection, steinstrasse, and perforation. The degree of these complications will also be measured.
Pain relief by the end of follow-up periodApril 30, 2018Participants will be followed up annually either by return visit or telephone call. Condition of abdominal pain or acute pancreatitis attack during follow-up will be measured. Pain relief at the end of the follow-up period was classified as complete relief (Izbicki pain score≤10) or partial relief (Izbicki pain score \>10 after a decrease of \>50%)

Secondary

MeasureTime frameDescription
Stone clearance as assessed by ERCP performed post-ESWLApril 30, 2016Stone clearance was evaluated at the ERCP performed post-ESWL, with complete clearance defined as clearance of \>90% of the main pancreatic duct stone volume, whereas partial clearance was defined as clearance of 50%-90% of the stone volume.
Physical and mental health assessed by SF-36 questionnaireApril 30, 2018Physical and mental health after treatment were assessed according to the scores on the SF-36 questionnaire.
Quality of life score assessed by the patientApril 30, 2018Quality of life score after treatment were assessed by the patient and ranged from 0 to 100, with higher scores indicating a better quality of life.
Body weightApril 30, 2018Body weight after treatment

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026